Zobrazeno 1 - 10
of 18
pro vyhledávání: '"C. Fred LeMaistre"'
Autor:
C. Fred LeMaistre, Minoo Battiwalla, Amir Steinberg, Wael Saber, Biju George, Siddhartha Ganguly, Theresa Hahn, Navneet S. Majhail, Naya He, Cesar O. Freytes, Staci D. Arnold, Jennifer M. Knight, Sachiko Seo, Ruta Brazauskas, Rammurti T. Kamble, Leslie Lehmann, Richard F. Olsson, Mahmoud Aljurf, Shahrukh K. Hashmi, Miguel Angel Diaz, Alok Srivastava, Christopher E. Dandoy, Hillard M. Lazarus, Jason Law, Nandita Khera, Baldeep Wirk, Ayami Yoshimi, Haydar Frangoul, Akshay Sharma, Neel S. Bhatt, Raquel M. Schears, David Szwajcer, Jaime M. Preussler, Ibrahim Ahmed, David Gómez-Almaguer, William A. Wood, Christine Duncan, Bipin N. Savani, Sherif M. Badawy, A. Samer Al-Homsi, Kira Bona, Jignesh Dalal, Hisham Abdel-Azim, Sara Beattie
Publikováno v:
Blood
Social determinants of health, including poverty, contribute significantly to health outcomes in the United States; however, their impact on pediatric hematopoietic cell transplantation (HCT) outcomes is poorly understood. We aimed to identify the as
Autor:
Minoo Battiwalla, Michael Tees, Ian W. Flinn, Jeremy Pantin, Tara Gregory, Michael Maris, Vikas Bhushan, Estil Vance, John Mathews, Carlos Bachier, Paul J. Shaughnessy, Dr. Aravind Ramakrishnan, Shahbaz Malik, Shahram Mori, Usama Gergis, Rocky Billups, Betsy Blunk, Dr. C. Fred LeMaistre, Navneet S. Majhail
Publikováno v:
Transplantation and Cellular Therapy. 29:S211
Autor:
Naya He, Christopher E. Dandoy, Michael A. Pulsipher, Richard F. Olsson, Adriana Seber, Richard Aplenc, Baldeep Wirk, Celalettin Ustun, Prakash Satwani, Franca Fagioli, Hillard M. Lazarus, David Szwajcer, Paulette Mehta, Hisham Abdel-Azim, Menachem Bitan, Susan K. Parsons, Cesar O. Freytes, David A. Rizzieri, Jignesh Dalal, Wael Saber, Staci D. Arnold, Yimei Li, Shahrukh K. Hashmi, Ruta Brazauskas, David I. Marks, Christine Duncan, Usama Gergis, C. Fred LeMaistre, Theresa Hahn, William A. Wood, Jennifer M. Knight, Amir Steinberg, Miguel Angel Diaz, Nandita Khera, Carmem Bonfim, Rammurti T. Kamble, Haydar Frangoul, Matthew Hall, Raquel M. Schears, Yoshiko Atsuta
Allogeneic hematopoietic stem cell transplantation (alloHCT) may be associated with significant morbidity and mortality, resulting in increased healthcare utilization (HCU). To date, no multicenter comparative cost analyses have specifically evaluate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7f59c1752f94ffc54b02e08bc2e97f31
http://hdl.handle.net/2318/1757449
http://hdl.handle.net/2318/1757449
Autor:
Christina Ullrich, Alison W. Loren, Gloria Gee, Bronwen E. Shaw, Beatrice Abbetti, Barry A. Schatz, C. Fred LeMaistre, Susan Doughtie, Theresa Hahn, Elizabeth Murphy, David J. Vanness, Linda J. Burns, Navneet S. Majhail, Lakshmanan Krishnamurit, Ellen M. Denzen, Mark B. Juckett, Susan Kullberg, Areej El-Jawahiri, Stacie D. Arnold, Doug Rizzo, Jeff B. Bender, Karen L. Syrjala, D. Kathryn Tierney, Mary M. Horowitz, William A. Wood, Shirley Johnson, Wael Saber, Alva Roche-Green, Kim Schmit-Pokorny
Publikováno v:
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 24(6)
The goal of patient-centered outcomes research (PCOR) is to help patients and those who care for them make informed decisions about healthcare. However, the clinical research enterprise has not involved patients, caregivers, and other non-providers r
Publikováno v:
Biology of Blood and Marrow Transplantation. 25:S421-S422
The Sarah Cannon Blood Cancer Network (SCBCN) consists of hematopoietic cell transplant (HCT) programs, 6 in the US and 3 in the UK, performing more than 1,100 autologous and allogeneic transplants annually with standard quality systems, patient care
Publikováno v:
Biology of Blood and Marrow Transplantation. 25:S419
Purpose To describe how SCBCN uses CIBMTR Portal data to define internal program benchmarks. Effective benchmarking is a way of establishing standards to detect performance gaps and potential causes contributing to performance levels [1]. Despite a p
Autor:
C. Fred LeMaistre, Fausto R. Loberiza
Publikováno v:
Biology of Blood and Marrow Transplantation. 11:241-246
Hematopoietic stem cell transplantation (HSCT) as a field of medicine has been subject to rapid development and evolution since its inception. Traditionally, HSCT has been used for therapy of a diverse group of malignancies, bone marrow failure state
Autor:
Rein Saral, Ronald J. Berenson, Shelly Heimfeld, Edward D. Ball, Richard E. Champlin, Kent Holland, Roy B. Jones, Elizabeth J. Shpall, Cindy Jacobs, C. Fred LeMaistre
Publikováno v:
Blood. 90:4313-4320
High-dose chemotherapy with hematopoietic progenitor cell support is administered increasingly to selected categories of patients with high-risk malignancies. Bone marrow and/or peripheral blood progenitor cells (PBPCs) are commonly cryopreserved wit
Autor:
Jerry A. Molitor, Peter A. McSweeney, J. Lee Nelson, Leona Holmberg, Howard M. Shulman, Mark H. Wener, Chien-Shing Chen, Federico Viganego, Bernadette McLaughlin, Maureen D. Mayes, J. David Godwin, Muneer H. Abidi, Daniel E. Furst, Rainer Storb, Ted Gooley, Leslie J. Crofford, Gretchen Henstorf, Richard A. Nash, C. Fred LeMaistre, James R. Seibold, Kevin T. McDonagh, Keith M. Sullivan
Publikováno v:
Blood. 110(4)
More effective therapeutic strategies are required for patients with poor-prognosis systemic sclerosis (SSc). A phase 2 single-arm study of high-dose immunosuppressive therapy (HDIT) and autologous CD34-selected hematopoietic cell transplantation (HC
Autor:
Janie Anderson, Stephanie Farnia, Jugna Shah, Navneet S. Majhail, George B. Selby, C. Fred LeMaistre, Elizabeth R. Vazquez, Peter A. McSweeney, Rocky Billups
Publikováno v:
Biology of Blood and Marrow Transplantation. 19(2):S275-S276